You have 9 free searches left this month | for more free features.

Condition

Byler Disease (1)

Medium-chain Acyl-CoA Dehydrogenase (MCAD) Deficiency (1)

Urea Cycle Disorder (1)

Overall Status

Completed (2)

No longer available (1)

Sign in for free

Phase

phase 1 (1)

phase 4 (1)

Sponsor

Horizon Therapeutics, LLC (1)

Robert Squires, Jr. (1)

University of Pittsburgh (1)

Collaborator

Horizon Pharma Ireland, Ltd., Dublin Ireland (1)

Intervention

ravicti (3)

Study Documents

Intervention Type

drug (3)

Funder Type

Other (2)

Industry (1)

Study Type

Interventional (2)

Expanded Access (1)

ravicti

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Byler Disease Trial (RAVICTI)

No longer available

Byler Disease

RAVICTI

(no location specified)

Feb 14, 2019

Urea Cycle Disorder Trial in Canada, United States (RAVICTI)

Completed

Has Results

Urea Cycle Disorder

RAVICTI

Los Angeles, California
+16 more

Feb 8, 2019

Medium-chain Acyl-CoA Dehydrogenase (MCAD) Deficiency Trial in Pittsburgh (Ravicti)

Completed

Has Results

Medium-chain Acyl-CoA Dehydrogenase (MCAD) Deficiency

Ravicti

Pittsburgh, Pennsylvania

Children's Hospital of Pittsburgh of UPMC

Sep 22, 2017